MainSleaze

This post is Part 2 in a series of two. OMICS Group are not content to spam through an ESP; they’re also spamming under bioprovider.com, a Domain by Proxy.

Spamming IP: 216.40.218.178

Spam headers:

Return-Path: <omx@lifescienceshome.com>
Received: from server1 (server1.bioprovider.com [216.40.218.178])
        by x (Postfix) with SMTP id x
        for <x>; Tue, 20 Mar 2012 11:4x:xx +0200 (EET)
Received: from server1[127.0.0.1] by server1[127.0.0.1]
        (SMTPD32); Tue, 20 Mar 2012 04:4x:xx -0500
Reply-To: omx@lifescienceshome.com
Message-ID: <x@lifescienceshome.com>
From: Omics Evolution Summit 2012 <omx@lifescienceshome.com>
To: x
Subject: George Church to Keynote at the Omics Evolution Summit 2012
Date: Tue, 20 Mar 2012 04:4x:xx -0500
MIME-Version: 1.0
Content-Type: text/html;
        charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

Human-readable spam content: None, the message does not have a text/plain part. Here’s the HTML:

If you can’t view this page, please visit: http://www.gtcbio.com/newsletter/OMXI-w.htm  x
George Church, Director of the Center for Computational Genetics at Harvard Medical School, to give Plenary Keynote Presentation at the Omics Evolution Summit in Boston, MA, May 29-31, 2012 Register and save up to $500 before the 20% discount ends on March 30th.
Dear Colleague, George Church, Professor of Genetics and Director of the Center for Computational Genetics at Harvard Medical School will be giving a plenary keynote presentation entitled “The Personal Genome Project – Open Access to Genome Sequences + Trait Data” at the Omics Evolution Summit to be held on May 29-31, 2012 at the Hyatt Harborside Hotel in Boston, MA. The Personal Genome Project enables open observation and critique of a large cohort “test-driving” comprehensive participatory personalized medicine. Since 2004, George Church and his team have helped push the cost of reading and writing DNA (and biological systems) down by a million-fold (5-fold faster exponential than Moore’s law) and enabled fully open-access human Genome+Environment=Trait (GET) data, stem cells, and clinical community curation / interpretation tools (Evidence.PersonalGenomes.org). Dr. Church will be speaking in the Plenary Keynote Session of the Omics Evolution Summit. Other keynote speakers in the session include Craig C Mello, Ph.D., Distinguished Professor of Molecular Medicine and Nobel Laureate, at the University of Massachusetts Medical School and HHMI, and Steven Burrill, CEO of Burrill & Company. The Omics Evolution Summit will bring together leading pharmaceutical and diagnostic companies, top scientists and government experts to discuss research and developments in drug discovery, new technologies and the evolving landscape of the industry in genomics, proteomics, RNAi, next-generation sequencing, epigenetics and protein kinases. The Summit will have six tracks that will allow attendees to engage in individual programs – or portions of all tracks – while enjoying networking opportunities with all attendees, speakers, poster presenters and exhibitors: 2nd Genomic & Proteomic Drug Discovery 2nd Next Generation Sequencing 2nd Epigenetics in Drug Discovery 3rd RNAi Research and Development 7th Protein Kinases in Drug Discovery Genome-wide Partnering & Dealmaking In addition, there is a Pre-Summit Clincal Sequencing Workshop on May 29th that will present an overview of sequencing product profiles and technical underpinnings as well as discuss from a user’s perspective the many issues of the implementation of Next-Generation Sequencing into the clinical space. Sign up today to save 20% off the regular price before March 30th! Or bring your team with a Register 2, the 3rd person goes free discount! Use discount code rcdvb.
KEYNOTE AND FEATURED SPEAKERS
George Church, Ph.D., Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School Rade Drmanac, Chief Scientific Officer, Complete Genomics Nathanael S. Gray, Ph.D., Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School Alexander Meissner, Ph.D., Assistant Professor, Harvard University, Senior Associate Member, the Broad Institute of MIT and Harvard Craig C. Mello, Ph.D., Distinguished Professor, Molecular Medicine, Nobel Laureate, University of Massachusetts Medical School; HHMI Rachel Meyers, Ph.D., Vice President, Research and RLD, Alnylam Rab Prinjha, Interim Head of Epinova Epigenetics DPU, Head of Biology, GlaxoSmithKline, UK John Quackenbush, Professor, Computational Biology and Bioinformatics, Dana-Farber Cancer Institute John J. Rossi, Ph.D., Lidow Family Endowed Professor and Chairman, Molecular and Cellular Biology, Beckman Research Institute, City of Hope Matthew Stanton, Ph.D., Head, RNA Optimization, Merck Richard M. Weinshilboum, Mary Lou and John H. Dasburg Professor, Cancer Genomics Research; Chair, Division of Clinical Pharmacology; Professor Molecular Pharmacology & Experimental Therapeutics and Medicine, Mayo Clinic College of Medicine Michael B. Yaffe, Ph.D., Professor, Biology and Biological Engineering, Massachusetts Institute of Technology Steven Burrill, Chief Executive Officer, Burrill & Company For a complete speaker list, click here.
Click the Conference title to view the agenda of each track: Clinical Sequencing Workshop 2nd Genomic & Proteomic Drug Discovery 2nd Next Generation Sequencing 2nd Epigenetics in Drug Discovery 3rd RNAi Research and Development 7th Protein Kinases in Drug Discovery Genome-wide Partnering & Dealmaking Sign up to attend the Clinical Sequencing Workshop on May 29th. And register for the Omics Evolution Summit to get access to all 6 tracks!
For Business Development & Exhibiting Opportunities contact Maribel Cortes, spex@gtcbio.com
UPCOMING CONFERENCES
2nd Annual Diabetes Summit Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th 5th Diabetes Drug Discovery and Development Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th 2nd Diabetes Partnering and Deal-making Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th Healthcare Centers of Excellence Pre-Summit Workshop May 15, 2012, Atlanta, GA 10% discount by Apr. 15th Healthcare Centers of Excellence Summit May 15-17, 2012, Atlanta, GA 10% discount by Apr. 15th Cancer Centers of Excellence Meeting May 15-17, 2012, Atlanta, GA 10% discount by Apr. 15th Diabetes Centers of Excellence Meeting May 15-17, 2012, Atlanta, GA 10% discount by Apr. 15th Cardiac Centers of Excellence Meeting May 15-17, 2012, Atlanta, GA 10% discount by Apr. 15th 2nd Infectious Diseases World Summit July 9-10, 2012, San Francisco, CA 10th Vaccines Research & Development: All Things Considered July 9-10, 2012, San Francisco, CA 20% discount by May. 9th 9th Anti-Infectives Partnering & Deal-making July 9-10, 2012, San Francisco, CA 20% discount by May. 9th Influenza Research & Development July 9-10, 2012, San Francisco, CA	8th Stem Cell Summit Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th 8th Stem Cell Research and Regenerative Medicine Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th Stem Cell Commercialization & Partnering Apr. 19-20, 2012, Boston, MA 10% discount by Mar. 19th Drug Discovery and Regulatory Summit June 7-8, 2012, San Diego, CA 6th Drug Design and Medicinal Chemistry June 7-8, 2012, San Diego, CA 20% discount by Apr. 7th Antibody Design and Drug Discovery June 7-8, 2012, San Diego, CA 20% discount by Apr. 7th Life Science Legal & Business Strategy June 7-8, 2012, San Diego, CA 20% discount by Apr. 7th Biospecimens and Biorepositories June 7-8, 2012, San Diego, CA 2nd Biomarker Europe Summit September, 2012 Zurich, Switzerland
This advertisement is sent to x from GTC, 434 W. Foothill Blvd, Monrovia, CA 91016. If you prefer not to receive further messages from this sender, please forward this email to remove@gtcbio.com or use the following link to unsubscribe http://gtcbio.com/unsubscribe.php?emailid=x